Reven today announced that it has licensed intellectual property, technology and knowledge pertaining to multiple owned patents supported by a decade of pre-clinical and clinical research in anti-inflammatory effects of bio-similar nutrients to ENS … Read More The post REVEN ANNOUNCES A STRATEGIC LICENSING PARTNERSHIP WITH ENLIGHTENED NUTRACEUTICAL SOLUTIONS, LLC (ENS) TO ALLOW ENS TO LEVERAGE REVEN’S CLINICAL RESEARCH IN ANTI-INFLAMMATORY AND ANTIOXIDANT MEDICINE TOWARD ITS EFFORTS TO DEVELOP NEW PROPRIETORY VITAMIN AND NUTRIENT BASED PRODUCTS. appeared first on Reven Pharmaceuticals .